Skip to main content
OpenTrials

Clinical trial condition

Recurrent Non-Small Cell Lung Carcinoma

Explore clinical trials studying Recurrent Non-Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

26 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Non-Small Cell Lung Carcinoma trial results

Completed

Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer

NCT00602797

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • CHI Health Saint Francis Grand Island, Nebraska, United States
  • Great Plains Regional Medical Center North Platte, Nebraska, United States
  • Veterans Administration Medical Center, Omaha Omaha, Nebraska, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Completed

Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

NCT00698815

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Arroyo Grande Community Arroyo Grande, California, United States
  • Kaiser Permanente-Baldwin Park Baldwin Park, California, United States
  • Kaiser Permanente-Bellflower Bellflower, California, United States
View all 129 locations
View Trial Details
Completed

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer

NCT01620190

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Anchorage Oncology Centre Anchorage, Alaska, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Bozeman Deaconess Hospital Bozeman, Montana, United States
View Trial Details
Completed

Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer

NCT00950365

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +19 more
Locations
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of Massachusetts Memorial Health Care Worcester, Massachusetts, United States
  • Albert Einstein College of Medicine The Bronx, New York, United States
  • Bronx River Medical Associates PC The Bronx, New York, United States
View Trial Details
Completed

Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer

NCT01866410

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View Trial Details
Completed

Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer

NCT00387465

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sidney Kimmel Cancer Center San Diego, California, United States
  • Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details

Related conditions